Cargando…

Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study

OBJECTIVE AND DESIGN: Fecal calprotectin (CLP) is widely known for its detection in stools of patients with inflammatory bowel diseases (IBDs), to investigate the intestinal inflammatory status. Current research is promoting the circulating protein role as a systemic inflammatory marker. However, mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cherubini, Fabio, Cristiano, Antonio, Valentini, Alessandra, Bernardini, Sergio, Nuccetelli, Marzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101083/ https://www.ncbi.nlm.nih.gov/pubmed/33956194 http://dx.doi.org/10.1007/s00011-021-01465-y

Ejemplares similares

Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
por: Cherubini, Fabio, et al.
Publicado: (2021)

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies
por: Cristiano, Antonio, et al.
Publicado: (2021)

Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
por: Cristiano, Antonio, et al.
Publicado: (2021)

Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
por: Cristiano, Antonio, et al.
Publicado: (2022)

Evaluation of the accuracy in the mucosal detection of anti-SARS-CoV-2 antibodies in nasal secretions and saliva
por: Fiorelli, Denise, et al.
Publicado: (2023)

Leptin, ghrelin and calprotectin: inflammatory markers in childhood asthma?
por: Cobanoglu, Nazan, et al.
Publicado: (2013)

SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
por: Nuccetelli, Marzia, et al.
Publicado: (2020)

Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus
por: Nuccetelli, Marzia, et al.
Publicado: (2021)

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
por: Bayrakci, Nergiz, et al.
Publicado: (2022)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

Calprotectin — A Novel Marker of Obesity
por: Mortensen, Ole Hartvig, et al.
Publicado: (2009)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico
por: Maldonado-Arriaga, Brenda, et al.
Publicado: (2021)

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes
por: Cristiano, Antonio, et al.
Publicado: (2023)

The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
por: Nicolai, Eleonora, et al.
Publicado: (2023)

Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
por: Pieri, Massimo, et al.
Publicado: (2022)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018)

Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
por: Pieri, Massimo, et al.
Publicado: (2022)

Meta-Analysis: Urinary Calprotectin for Discrimination of Intrinsic and Prerenal Acute Kidney Injury
por: Chen, Jia-Jin, et al.
Publicado: (2019)

Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
por: Roda, Juliana, et al.
Publicado: (2022)

Serum Calprotectin Is a Potential Marker in Patients with Asthma
por: Lee, Yun-Gi, et al.
Publicado: (2020)

Calprotectin as new potential clinical marker for multiple myeloma
por: Khosravi, Parisa, et al.
Publicado: (2023)

Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
por: Guerrieri, Mariapia, et al.
Publicado: (2021)

Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis
por: Huang, Jinxian, et al.
Publicado: (2017)

Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID‐19
por: Lee, Anna, et al.
Publicado: (2021)

Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19
por: Norman, Gary L., et al.
Publicado: (2022)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Calprotectin can play an inflammatory role in acne vulgaris
por: Korkmaz, Selma, et al.
Publicado: (2018)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499
por: Guerrieri, Mariapia, et al.
Publicado: (2023)

Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke
por: Marta-Enguita, Juan, et al.
Publicado: (2021)

Calprotectin as a diagnostic marker for sepsis: A meta-analysis
por: Gao, Rong-Yue, et al.
Publicado: (2022)

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
por: Silvin, Aymeric, et al.
Publicado: (2020)

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
por: Chapuis, Nicolas, et al.
Publicado: (2022)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases
por: Karaky, Mohamad, et al.
Publicado: (2022)

MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy
por: Rapanotti, Maria Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c3q9q3bchlq757dg9hqspl3kvm